Michael Buschmann came to Mason with over 20 years of experience at École Polytechnique in Montreal. He is a world-class researcher who has made fundamental and translational contributions to the fields of biomechanics, biomaterials, and nanomedicine.
Buschmann earned his PhD in 1992 in Medical Engineering and Medical Physics from the Massachusetts Institute of Technology in the Harvard-MIT Division of Health Sciences and Technology and conducted his postdoctoral studies at the ME Mueller Institute of Biomechanics, University of Bern, Switzerland. He became a faculty member at École Polytechnique in 1994, becoming a full professor in 2001. His research achievements include more than 150 peer-reviewed articles, over 330 conference proceedings, 5 book chapters, over 75 invited presentations, 19 patent applications (7 granted), over 12,000 citations, and an h-index of 56. He has graduated 20 PhD students, 17 MSc students, and supervised 14 postdoctoral fellows. During his academic career at École Polytechnique, he obtained over $50M in external research funding as principal investigator.
Buschmann’s research work has been recognized by 19 prizes/awards, and his abilities as an educator earned him numerous teaching awards at École Polytechnique. He has received many awards for his research, including the prestigious Canada Research Chair Tier 1 in 2001, the Melville Medal of the American Society of Mechanical Engineering (ASME) in 1997, and Article of the Year for ASME Journal of Biomedical Engineering in 1996. He has been the driving force behind four biotech startup companies as founder or principal inventor: Biosyntech Inc., sold to Smith & Nephew; Biomomentum Inc.; ANRis Pharma; and Ortho Regerative Technologies Inc.